Latest News

Intercontinental Exchange (ICE) stock is back in focus after the company and NATIVX outlined plans for GPU compute futures contracts tied to the COIL Index, linking tokenized compute pricing with ICE’s existing energy markets. See our latest analysis for Intercontinental Exchange. Despite the latest GPU compute futures announcement and a series of new product launches in economic indicators and environmental markets, Intercontinental Exchange’s recent trading has been weak, with the share...

CarGurus (CARG) drew fresh attention after its stock rose 3.7% following a move to require dealers to disclose all fees on used vehicle listings, tightening the platform’s all in pricing and transparency rules. See our latest analysis for CarGurus. The latest fee transparency move comes after a strong recent run in CarGurus stock, with a 7 day share price return of 12.63% and 30 day share price return of 18.20%. In contrast, the year to date share price return is down 6.67% and the 3 year...

CRISPR Therapeutics (CRSP) is drawing fresh attention after being added to multiple Russell growth benchmarks, including the Russell 2000, 2500, 3000, Small Cap Comp Growth and 3000E Growth indexes. See our latest analysis for CRISPR Therapeutics. The index additions come after a period of steady momentum for CRISPR Therapeutics, with a 90-day share price return of 12.34% and a 1-year total shareholder return of 7.64%. However, the 5-year total shareholder return is down 60.91%. If the CRISPR...

In recent days, EQ Resources has been swept up in stronger investor interest across critical minerals, with tungsten’s role in industrial, defence and manufacturing applications drawing fresh attention to the company’s Australian and Spanish operations. This renewed focus underscores EQ Resources’ position as a Western-linked tungsten supplier amid geopolitical concerns over supply security and growing policy support for critical minerals. With this backdrop of heightened critical minerals...

Why Mirum Pharmaceuticals Stock Is Back in Focus Mirum Pharmaceuticals (MIRM) is in the spotlight after its shares rallied 5.5% following positive pivotal phase II data and an FDA priority review for rare disease drug candidate zilurgisertib. The stock has also logged a 9 day winning streak and a 25% move, lifting Mirum Pharmaceuticals market value to about US$7.3b, which may encourage investors to reassess what is already reflected in the current price. See our latest analysis for Mirum...

In late June 2026, Monster Beverage Corporation was added to multiple Russell value and defensive indexes, following earlier first-quarter 2026 results that exceeded earnings and revenue expectations and the authorization of a US$500.00 million stock repurchase program. This combination of stronger-than-expected financial performance, index inclusions, and a fresh buyback authorization highlights Monster’s growing relevance in value-oriented portfolios and institutional positioning. Next,...

Gold’s sharp rebound after weaker U.S. private payrolls data and renewed focus on the upcoming nonfarm payrolls report have put precious metals mining stocks back in the spotlight. With markets weighing a possible September U.S. rate hike, softer oil prices easing some inflation worries and the Federal Reserve reaffirming its 2% inflation goal, investors are reassessing how to position around interest rate and commodity price shifts. This article walks through 3 stocks from a Precious Metals...

Skanska (OM:SKA B) just added a new US infrastructure project to its backlog, signing a US$87 million Dock Bridge rehabilitation contract with Amtrak in Newark, New Jersey, now reflected in second quarter 2026 order bookings. See our latest analysis for Skanska. These new contracts in the US, UK and Nordics, alongside the A46 cancellation, come as Skanska’s share price sits at SEK259.2, with a 30 day share price return of 5.45% and a 90 day share price return of 8.27%, while the 1 year total...

Advantest (TSE:6857) has been back in focus after announcing a collaboration with OpenLight to develop scalable, high volume silicon photonics testing solutions, a move closely watched by investors in AI and high performance computing. See our latest analysis for Advantest. Despite the latest collaboration news and a recent buyback update, Advantest’s share price has pulled back sharply in the short term, with a 1 day share price return of down 9.95% and a 7 day share price return of down...

Geopolitics, inflation surprises and shifting central bank expectations are reshaping the opportunity set in European equities, and not always in obvious ways. With oil prices easing as the US Iran risk premium unwinds and euro area inflation readings coming in softer than expected, some large and mid cap stocks look better positioned than others for this mix of lower energy costs and uneven policy moves. This article walks through three stocks from our euro area screener that appear...

Index removals put Progressive in focus for benchmark driven investors Progressive (PGR) was removed from several Russell growth indices on June 27, a technical shift that may affect benchmark tracking flows and prompt investors to reassess how they view the stock. See our latest analysis for Progressive. Despite being removed from several Russell growth indices, Progressive’s recent trading has been firm, with a 1-month share price return of 16.94% and a 3-month share price return of 15.39%...

NANO Nuclear Energy has recently been removed from several Russell growth and small-cap benchmarks, while also reporting leadership changes in its reactor development team and progress in the U.S. Nuclear Regulatory Commission’s review of the KRONOS microreactor construction permit at the University of Illinois Urbana-Champaign. At the same time, early-stage discussions around potential investment from a UAE-linked firm and a new Abu Dhabi memorandum of understanding highlight growing...

United Rentals (NYSE:URI) has been added to several major Russell growth indexes, including the Russell 1000 Growth, 3000 Growth, 3000E Growth, and Midcap Growth benchmarks. These index inclusions are recent and reflect changes in how United Rentals is classified across key growth-oriented benchmarks that many institutional and passive funds track. United Rentals enters this index reshuffle with a share price of $1,111.76 and a record of recent returns of 2.6% over the past week, 11.4% over...

Visa stock has delivered a 51.9% total return over the past five years. At around US$351 per share, however, the valuation checks highlight some tension between a solid track record and a price that does not appear to be an obvious bargain. The intrinsic value estimate from the Excess Returns model suggests Visa is roughly in line with its assessed fair value, while traditional earnings multiples indicate the stock is trading at a premium. Over five years, Visa has returned 51.9%, which is a...

Recent commentary around Colgate-Palmolive (CL) centers on management’s 2030 plan, as investors weigh how premium product expansion and tighter digital plus in store integration might support the stock’s appeal after several years of organic sales growth. See our latest analysis for Colgate-Palmolive. Colgate-Palmolive’s recent 1-month share price return of 4.9% and year-to-date share price return of 19.4%, with the stock now at $92.76, suggest investors are increasingly pricing in the 2030...

BAE Systems stock has generated a very large 5 year return, yet the latest valuation work suggests the shares may still trade below an intrinsic value estimate, with both the Discounted Cash Flow (DCF) model and market multiples pointing to potential undervaluation. BAE Systems has returned around 323.8% over 5 years, which puts recent valuation questions front and center for anyone considering the stock today. New defence work, such as the recent Vantor satellite collaboration, can support...

Over the last 7 days, the United States market has risen by 1.6%, contributing to a 21% increase over the past year, with earnings projected to grow by 19% annually. In this environment of robust growth, identifying stocks that are potentially undervalued can offer investors opportunities to capitalize on discrepancies between market price and intrinsic value estimates.

Over the last 7 days, the United States market has risen 1.6%, and in the past year, it has climbed 21%, with earnings forecasted to grow by 19% annually. In light of these positive trends, identifying stocks that combine financial robustness with growth potential is crucial for investors looking to capitalize on current conditions. Penny stocks, though often seen as a relic from earlier trading days, can still offer significant opportunities when supported by strong fundamentals; we'll...

Over the last 7 days, the United States market has risen by 1.6%, contributing to a substantial 21% increase over the past year, with earnings forecasted to grow by 19% annually. In this environment of robust growth, stocks with high insider ownership can be particularly appealing as they often indicate strong confidence from those closest to the company's operations and future prospects.

Over the last 7 days, the United States market has risen by 1.6% and is up 21% over the past year with earnings forecasted to grow by 19% annually. In this favorable environment, selecting dividend stocks like Autoliv that offer consistent income and potential for growth can enhance your portfolio's stability and returns.

In recent weeks, Madison Investments added Moelis & Company to its Madison Mid Cap Fund, citing an attractive valuation after the stock weakened amid concerns that private credit market conditions could weigh on M&A volumes. The move highlights how some institutional investors view Moelis as a high-quality, underappreciated advisory business positioned to benefit as market conditions and deal activity evolve. We’ll now explore how Madison Investments’ valuation-driven entry into Moelis...

Evotec (XTRA:EVT) is back in focus after Just – Evotec Biologics rolled out J.TRAIN, a turnkey platform that lets biopharmaceutical companies install its continuous biologics manufacturing technology directly inside their own facilities. See our latest analysis for Evotec. While J.TRAIN is drawing attention to Evotec's biologics capabilities, the stock price tells a mixed story, with a 1-day share price return of 1.94% and a 90-day share price return of 13.15% set against a 1-year total...

Japan’s consumer staples sector is under fresh scrutiny after the Japan Fair Trade Commission opened a price fixing probe into major ice cream makers, just as higher import costs, a weak yen and a 1% policy rate are forcing companies to rethink pricing. At the same time, talk of possible VAT cuts on food could reshape demand and margins. For investors, this combination of regulatory risk and policy support creates both potential openings and traps. This article highlights 3 Japanese consumer...

DXP Enterprises was recently added to the Russell 2000 Defensive Index and Russell 2000 Growth-Defensive Index, enhancing its profile among institutional investors. This index inclusion, combined with market focus on an upcoming earnings report that is projected to show higher earnings per share and revenue, is drawing increased attention to DXP’s business outlook. We’ll now examine how DXP’s inclusion in key Russell 2000 defensive indices may influence its existing investment narrative...